Table 1.
Clinical characteristics of 31 pediatric patients with PAAF
| Case | Age | Sex | Tumor location | APA on first resection or other resection | Resection type | Adjuvant treatment | Recurrence interval (months) | Status at last follow-up | OS (months) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 1.9 | M | Optic chiasm | De novo | STR | CT | 9.6 | A | 27.4 |
| 2 | 13.0 | M | Right cerebellar hemisphere | De novo | GTR | None | None | A | 3.7 |
| 3 | 4.2 | F | Cerebellar hemispherse | De novo | STR | None | 10.8 | A | 38.3 |
| 4 | 0.4 | M | Hypothalamus | De novo | PR | CT | 2.4 | A | 71.3 |
| 5 | 3.3 | M | Left cerebellar hemisphere | De novo | GTR | None | None | A | 15.6 |
| 6 | 0.7 | F | Hypothalamus | De novo | PR | CT | 2.1 | A | 86.1 |
| 7 | 1.0 | M | Right cerebellar hemisphere | De novo | STR | None | 3.1 | A | 39.4 |
| 8 | 10.0 | F | Left cerebellar hemisphere | De novo | GTR | None | None | A | 4.1 |
| 9 | 5.5 | F | Right cerebellar hemisphere | De novo | GTR | None | None | A | 6.8 |
| 10 | 0.4 | M | Optic chiasm | De novo | PR | CT | 8.2 | DOD | 27.5 |
| 11 | 10.1 | F | Cerebellar vermis | De novo | STR | None | None | A | 24.6 |
| 12 | 5.3 | F | Left cerebellar hemisphere | De novo | GTR | None | None | A | 13.3 |
| 13 | 0.5 | F | Hypothalamus | De novo | PR | CT | 3.4 | DOD | 46.7 |
| 14 | 15.0 | M | Hypothalamus | De novo | PR | None | None | A | 27.6 |
| 15 | 7.8 | F | Optic chiasm | Malignant transformation | STR | CT + RT | 29.4 | A | 103.8 |
| 16 | 3.3 | F | Cerebellar vermis | De novo | STR | None | 1.0 | A | 6.5 |
| 17 | 1.7 | M | Right cerebellar hemisphere | De novo | STR | None | None | A | 8.8 |
| 18 | 9.8 | M | Left cerebellar peduncle | Malignant transformation | PR | CT | 11.9 | A | 51.1 |
| 19 | 12.7 | F | Right cerebellar hemisphere | De novo | GTR | None | 39.4 | A | 53.5 |
| 20 | 15.2 | F | Right cerebellar hemisphere | Malignant transformation | GTR | None | None | A | 49.7 |
| 21 | 13.0 | M | Vermis and left cerebellar hemisphere | De novo | STR | None | None | A | 2.5 |
| 22 | 8.8 | F | Hypothalamus | Malignant transformation | PR | CT | None | A | 1.4 |
| 23 | 7.5 | M | 3rd ventricle | De novo | PR | CT | 13.8 | A | 13.7 |
| 24 | 0.6 | F | Hypothalamus | De novo | PR | none | None | DOS | 0.0 |
| 25 | 15.4 | F | Hypothalamus | Malignant transformation | PR | RT | 11.5 | A | 37.7 |
| 26 | 0.8 | F | Spinal | De novo | PR | CT | 1.2 | A | 12.9 |
| 27 | 8.0 | F | Right parietal | De novo | GTR | CT + RT | 13.4 | DOD | 37.0 |
| 28 | 15.9 | F | Hypothalamus | Malignant transformation | STR | CT | 6.9 | DOD | 8.2 |
| 29 | 1.6 | F | Hypothalamus | De novo | PR | CT | 1.0 | A | 18.9 |
| 30 | 7.0 | F | Spinal | De novo | PR | None | None | A | 1.7 |
| 31 | 8.8 | M | Bulbo-medullary junction | De novo | GTR | CT | 2.5 | A | 12.2 |
A alive, CT chemotherapy, DOD dead of disease, DOS dead of surgery, F female, GTR gross total resection, M male, PR partial resection, RT radiotherapy, STR subtotal resection